We are live on
!
Find out more
P
Pitcairn Portfolio holdings
AUM
$1.27B
1-Year Est. Return
23.64%
This Fund
S&P 500
This Quarter
Est. Return
+2.93%
1 Year Est. Return
+23.64%
3 Year Est. Return
+111.21%
5 Year Est. Return
+126.49%
10 Year Est. Return
+390.83%
AUM
$1.41B
AUM Growth
+$98.5M
(+7.5%)
Cap. Flow
+$84.2M
Cap. Flow
% of AUM
5.98%
Top 10 Holdings %
Top 10 Hldgs %
47.71%
Holding
642
New
69
Increased
321
Reduced
195
Closed
41
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR MSCI ACWI ex-US ETF
CWI
|
+$39.6M |
| 2 |
Procter & Gamble
PG
|
+$12.3M |
| 3 |
VanEck Merk Gold Trust
OUNZ
|
+$8.97M |
| 4 |
iShares Russell 1000 ETF
IWB
|
+$6.75M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.57M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Gold Trust
IAU
|
+$7.38M |
| 2 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$4.33M |
| 3 |
Enterprise Products Partners
EPD
|
+$4.18M |
| 4 |
iShares Russell 3000 ETF
IWV
|
+$3.35M |
| 5 |
MPLX
MPLX
|
+$2.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 25.12% |
| 2 | Technology | 12.09% |
| 3 | Financials | 8.07% |
| 4 | Healthcare | 7.84% |
| 5 | Consumer Discretionary | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAGE
526
DELISTED
Sage Therapeutics
SAGE
| $257K | 0.02% |
+3,426
| New | +$281K |
|
527
Arthur J. Gallagher & Co
AJG
$62.4B
| $256K | 0.02% |
2,047
+3
| +0.1% | +$362 |
|
|
EPAY
528
DELISTED
Bottomline Technologies Inc
EPAY
| $255K | 0.02% |
+5,633
| New | +$271K |
|
529
Axsome Therapeutics
AXSM
$12.4B
| $253K | 0.02% |
+4,475
| New | +$315K |
|
530
Zscaler
ZS
$22.8B
| $252K | 0.02% |
1,471
+368
| +33% | +$73.1K |
|
531
Sprouts Farmers Market
SFM
$6.95B
| $250K | 0.02% |
9,421
-3,430
| -27% | -$78K |
|
532
General Motors
GM
$74.9B
| $249K | 0.02% |
+4,335
| New | +$230K |
|
533
Delta Air Lines
DAL
$55.1B
| $248K | 0.02% |
5,118
-417
| -8% | -$18.4K |
|
534
PTC
PTC
$13.3B
| $248K | 0.02% |
+1,800
| New | +$240K |
|
|
GTY
535
Getty Realty Corp
GTY
$2.09B
| $247K | 0.02% |
8,718
+147
| +2% | +$4.11K |
|
536
Huntington Ingalls Industries
HII
$11.5B
| $247K | 0.02% |
1,202
-577
| -32% | -$103K |
|
537
VeriSign
VRSN
$25.1B
| $246K | 0.02% |
1,234
+79
| +7% | +$15.5K |
|
|
IAA
538
DELISTED
IAA, Inc. Common Stock
IAA
| $246K | 0.02% |
4,460
| – | – |
|
|
MRTX
539
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $245K | 0.02% |
1,429
-243
| -15% | -$48.1K |
|
540
Levi Strauss
LEVI
$9.29B
| $242K | 0.02% |
+10,124
| New | +$227K |
|
541
Quest Diagnostics
DGX
$25.2B
| $241K | 0.02% |
1,874
+187
| +11% | +$23K |
|
542
Hilton Worldwide
HLT
$73.8B
| $241K | 0.02% |
1,989
+79
| +4% | +$9.13K |
|
543
First American
FAF
$7.42B
| $240K | 0.02% |
4,252
-450
| -10% | -$24.6K |
|
544
Service Corp International
SCI
$11B
| $239K | 0.02% |
4,685
-188
| -4% | -$9.41K |
|
545
Citizens Financial Group
CFG
$30.4B
| $237K | 0.02% |
+5,362
| New | +$223K |
|
546
Hershey
HSY
$35.2B
| $235K | 0.02% |
1,490
-218
| -13% | -$32.8K |
|
547
Mercantile Bank Corp
MBWM
$997M
| $234K | 0.02% |
+7,207
| New | +$217K |
|
548
Palo Alto Networks
PANW
$265B
| $234K | 0.02% |
+4,368
| New | +$260K |
|
549
Sarepta Therapeutics
SRPT
$1.66B
| $234K | 0.02% |
3,138
+1,151
| +58% | +$106K |
|
550
Corpay
CPAY
$24B
| $234K | 0.02% |
870
-170
| -16% | -$46.2K |
|
Similar funds
SFI
WCWM
BA
SAM
4CM
SIMG
HT
BCM
Pitcairn's Q1 2021 Portfolio in Review
As of Q1 2021, Pitcairn held 642 positions worth $1.41B, up 7.5% from $1.31B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Pitcairn deployed $84.2M of net new capital in Q1 2021, opening 69 new positions and adding to 321 existing holdings. Its largest new stake was Veeva Systems: 8,502 shares worth $2.22M.
By sector, the portfolio is most concentrated in Consumer Staples at 25% of assets, down from 29% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares Gold Trust, an estimated $7.38M trimmed.
- Pitcairn's largest Q1 2021 buy was Veeva Systems: 8,502 shares worth $2.22M.
- Pitcairn added most to State Street SPDR MSCI ACWI ex-US ETF in Q1 2021, an estimated $39.6M increase.
- Pitcairn's biggest Q1 2021 reduction was iShares Gold Trust, cutting an estimated $7.38M.
- Pitcairn fully exited Magellan Midstream Partners, L.P. in Q1 2021, selling an estimated $4.33M.
- Pitcairn's ten largest holdings make up 48% of its $1.41B portfolio in Q1 2021.
- Pitcairn opened 69 new positions and closed 41 in Q1 2021.
- Pitcairn's portfolio value rose 7.5% quarter-over-quarter to $1.41B.
Based on Pitcairn's 13F filing for Q1 2021, filed 10 May 2021.